Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Janssen promotes R&D exec into newfound data science role
Following in the footsteps of an increasing number of biopharmas that want to use data to get more bang for their buck in R&D, Johnson & Johnson has promoted Najat Khan, Ph.
Avrobio taps Magenta’s ADC in ongoing quest to improve gene therapy conditioning
Avrobio is working to make conditioning, a necessary step for some gene therapies, safer.
With the world waiting, Roche socks $459M into COVID-19 antibody test production
Roche scored a major win with the FDA's backing for its COVID-19 antibody tests last week in a field marked by products of questionable quality.
Gilead, working on its own remdesivir ramp-up, scouts licensing partners for global production
Gilead Sciences can only produce so much of its newly authorized COVID-19 drug remdesivir, so it’s scouting other companies to bolster global supply.
US OK's AZ' Farxiga for heart failure with reduced ejection fraction
US regulators have approved AstraZeneca’s Farxiga (dapagliflozin) to cut the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (...
Alexion to Buy Portola in $1.4 Billion Effort to Diversify
Alexion Pharmaceuticals Inc.
Crescendo links with CRUK to progress cancer therapy
Crescendo Biologics and Cancer Research UK have entered into a Clinical Development Partnership to progress one of Crescendo’s novel bispecific Humabody immunotherapies, CB213, into clinical trials ...
Newron drops development of sarizotan in Rett syndrome
Shares in Newron Pharmaceuticals have taken a massive hit from the failure of sarizotan to show a clear benefit in patients with Rett syndrome, a severe neurodevelopmental disorder primarily affecting...
Menarini to buy Stemline for up to $677 million
Menarini is to purchase Stemline Therapeutics in a deal valued at up to $677 million, establishing its presence in the US biopharma market.
EU approves label update for AZ' Lokelma
European regulators have approved a label update for AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) to include a dosing regimen specifically to treat hyperkalaemia in patients with e...
Vicore Pharma bags MHRA nod for COVD-19 trial in record time
Vicore Pharma has been given the green light by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to start a Phase II clinical trial assessing a potential COVID-19 therap...
FDA grants Gilead’s remdesivir emergency authorization for COVID-19 treatment
The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.
332
333
334
335
336
337
338
339
340
